GlassScriptPhysician profile
Timothy A Scully
NPI 1538113394
$633.75
in general payments reported to CMS, 2019-2025
14 companies · $13.60 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $77.51 · 2021: $14.43 · 2022: $95.67 · 2023: $193 · 2024: $106 · 2025: $13.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.52 | 2019-2021 | |
| Pfizer INC. | $118.51 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $71.06 | 2019 | |
| Merck Sharp & Dohme LLC | $61.30 | 2022-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $44.85 | 2022-2024 | Eliquis |
| United Therapeutics Corporation | $32.73 | 2023 | |
| La Jolla Pharmaceutical Company | $30.48 | 2023 | Giapreza |
| Edwards Lifesciences Corporation | $25.84 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inari Medical, INC. | $19.19 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $18.09 | 2022 | |
| Philips North America LLC | $14.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.79 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $13.95 | 2024 | Fasenra |
| Ambu INC. | $13.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Scully listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.